BACKGROUND: We have demonstrated previously that in vivo supplementation of tetrahydrobiopterin (BH₄); a co-factor for neuronal nitric oxide synthase (nNOS) significantly restored delayed gastric emptying and attenuated nitrergic relaxation in diabetic rat. In this study, we have investigated whether supplementation of sepiapterin (SEP), a precursor for BH₄ biosynthesis via salvage pathway restores gastric emptying and nitrergic system in female diabetic rats. METHODS: Diabetic rats (streptozotocin-induced) were supplemented with BH₄ or SEP (20 mg kg⁻¹ body weight). Gastric nitrergic relaxation in the presence or absence of high glucose and SEP were measured by electric field stimulation. Gastric muscular strips from healthy or diabetic female rats were incubated in the presence or absence of high glucose, SEP and/or methotrexate (MTX). Nitric oxide release was measured colorimetrically by NO assay kit. The expression of nNOSα and dimerization was detected by Western blot. KEY RESULTS: In vitro studies on gastric muscular tissues showed that MTX, an inhibitor of BH₄ synthesis via salvage pathway, significantly decreased NO release. In vivo treatment with MTX reduced both gastric nitrergic relaxation and nNOSα dimerization. Supplementation of SEP significantly attenuated delayed gastric emptying in diabetic rats. In addition, SEP supplementation restored impaired nitrergic relaxation, gastric nNOSα protein expression, and dimerization in diabetic rats. CONCLUSIONS & INFERENCES: The above data suggests that supplementation of SEP accelerated gastric emptying and attenuated reduced gastric nNOSα expression, and dimerization. Therefore, SEP supplementation is a potential therapeutic option for female patients of diabetic gastroparesis.
BACKGROUND: We have demonstrated previously that in vivo supplementation of tetrahydrobiopterin (BH₄); a co-factor for neuronal nitric oxide synthase (nNOS) significantly restored delayed gastric emptying and attenuated nitrergic relaxation in diabeticrat. In this study, we have investigated whether supplementation of sepiapterin (SEP), a precursor for BH₄ biosynthesis via salvage pathway restores gastric emptying and nitrergic system in female diabeticrats. METHODS:Diabeticrats (streptozotocin-induced) were supplemented with BH₄ or SEP (20 mg kg⁻¹ body weight). Gastric nitrergic relaxation in the presence or absence of high glucose and SEP were measured by electric field stimulation. Gastric muscular strips from healthy or diabetic female rats were incubated in the presence or absence of high glucose, SEP and/or methotrexate (MTX). Nitric oxide release was measured colorimetrically by NO assay kit. The expression of nNOSα and dimerization was detected by Western blot. KEY RESULTS: In vitro studies on gastric muscular tissues showed that MTX, an inhibitor of BH₄ synthesis via salvage pathway, significantly decreased NO release. In vivo treatment with MTX reduced both gastric nitrergic relaxation and nNOSα dimerization. Supplementation of SEP significantly attenuated delayed gastric emptying in diabeticrats. In addition, SEP supplementation restored impaired nitrergic relaxation, gastric nNOSα protein expression, and dimerization in diabeticrats. CONCLUSIONS & INFERENCES: The above data suggests that supplementation of SEP accelerated gastric emptying and attenuated reduced gastric nNOSα expression, and dimerization. Therefore, SEP supplementation is a potential therapeutic option for female patients of diabetic gastroparesis.
Authors: Pandu R R Gangula; Sutapa Mukhopadhyay; Kalpana Ravella; Shijie Cai; Keith M Channon; Robert E Garfield; Pankaj J Pasricha Journal: Am J Physiol Gastrointest Liver Physiol Date: 2010-02-25 Impact factor: 4.052
Authors: M Zandecki; P Vanden Berghe; I Depoortere; K Geboes; T Peeters; J Janssens; J Tack Journal: Neurogastroenterol Motil Date: 2008-02-25 Impact factor: 3.598
Authors: Harvey L Levy; Andrzej Milanowski; Anupam Chakrapani; Maureen Cleary; Philip Lee; Friedrich K Trefz; Chester B Whitley; François Feillet; Annette S Feigenbaum; Judith D Bebchuk; Heidi Christ-Schmidt; Alex Dorenbaum Journal: Lancet Date: 2007-08-11 Impact factor: 79.321
Authors: Pandu R R Gangula; William L Maner; Maria-Adelaide Micci; Robert E Garfield; Pankaj Jay Pasricha Journal: Am J Physiol Gastrointest Liver Physiol Date: 2007-03 Impact factor: 4.052
Authors: Cassandra R Stewart; Nneka Obi; Elodie C Epane; Alexander A Akbari; Leslie Halpern; Janet H Southerland; Pandu R Gangula Journal: J Periodontol Date: 2016-01-16 Impact factor: 6.993
Authors: P R Gangula; V Chinnathambi; A B Hale; S Mukhopadhyay; K M Channon; K Ravella Journal: Neurogastroenterol Motil Date: 2011-03-18 Impact factor: 3.598
Authors: Sutapa Mukhopadhyay; Konjeti R Sekhar; Ashley B Hale; Keith M Channon; Gianrico Farrugia; Michael L Freeman; Pandu R Gangula Journal: Free Radic Biol Med Date: 2011-05-04 Impact factor: 7.376